It's a minor mystery in the drug world that's become a topic of debate among AstraZeneca (AZN)'s Symbicort sales staff: Why, in TV commercials for the asthma drug, is the presenter represented as a ...

AstraZeneca’s Don Apruzzese, formerly senior director of consumer marketing, is moving over to become regional commercial leader on the Symbicort for asthma launch, scheduled for mid-2007. In a world ...

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...

SYMBICORT is a combination therapy indicated for the long-term maintenance treatment of asthma in patients 12 years of age and older. (12) Administered twice daily, SYMBICORT is a combination of two ...

The Food and Drug Administration has given tentative approval to Viatris and Kindeva Drug Delivery for their Symbicort generic (budesonide/formoterol fumarate ...

The SMART (Symbicort Maintenance and Reliever Therapy) approach allows patients to increase the dose of Symbicort (a combination of an inhaled corticosteroid and long-acting bronchodilator) during ...

After seeing four of its patents for its Symbicort tossed aside, AstraZeneca has gained a key victory in defense of its blockbuster inhaler. A federal court in West Virginia upheld the company’s claim ...

Wilmington, DE – June 4, 2008 – AstraZeneca (NYSE: AZN) today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...